Presidential address: Value, viability, and valves

Journal of Thoracic and Cardiovascular Surgery

Volumn 124, Issue 1, 2002, Pages 1-6

  Clarke, David R ^a  

^a CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; ANTICOAGULATION; AORTA GRAFT; AORTA VALVE REGURGITATION; CALCIFICATION; CONFERENCE PAPER; CORONARY ARTERY BLOOD FLOW; COST EFFECTIVENESS ANALYSIS; FALLOT TETRALOGY; GRAFT SURVIVAL; HEART FUNCTION; HEART SURGERY; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HEMODYNAMICS; HUMAN; MITRAL VALVE COMMISSUROTOMY; MITRAL VALVE STENOSIS; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; REOPERATION; SURGICAL TECHNIQUE; SURVIVAL; THROMBOEMBOLISM; ALLOTRANSPLANTATION; ARTICLE; AUTOTRANSPLANTATION; BIOPROSTHESIS; HEART VALVE; PROSTHESIS;

BIOPROSTHESIS; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEART VALVES; HUMANS; PROSTHESIS DESIGN; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036631485     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2002.123705     Document Type: Conference Paper

References (60)

1. Jarcho S. Theodore Tuffier on experimental surgery of heart valves. Am J Cardiol. 1969;23:73-5.
2. Cutler EC, Levine SA. Cardiotomy and valvulotomy for mitral stenosis: experimental observations and clinical notes concerning an operated case with recovery. Boston Med J. 1923;188:1023-7.
3. Souttar HS. Surgical treatment of mitral stenosis. BMJ. 1925;2:603-6.
4. Brock RC. Pulmonary valvulotomy for the relief of congenital pulmonary stenosis. BMJ. 1948;1:1121-6.
5. Swan H, Kortz A. Direct vision trans-aortic approach to the aortic valve during hypothermia: experimental observations and report of a successful clinical case. Ann Surg. 1956;144:205-14.
6. Bailey CP. The surgical treatment of mitral stenosis (mitral commissurotomy). Dis Chest. 1949;15:377-97.
7. Harken DE, Ellis LB, Ware PF, Norman LR. The surgical treatment of mitral stenosis. I. Valvuloplasty. N Engl J Med. 1948;239:801-9.
8. Hufnagel CA. Aortic plastic valvular prosthesis. Bull Georgetown Univ Med Center. 1951;4:128-30.
9. Lam CR, Aram HH, Munnell ER. Experimental study of aortic valve homografts. Surg Gynecol Obstet. 1952;94:129-35.
10. Murray G. Homologous aortic-valve-segment transplants as surgical treatment for aortic and mitral insufficiency. Angiology. 1956;7:466-71.
11. Warden HE, Cohen M, Read RC, Lillehei CW. Controlled cross circulation for open intracardiac surgery: physiologic studies and results of creation and closure of ventricular septal defects. J Thorac Surg. 1954;28:331-43.
12. Gibbon JH Jr. Application of mechanical heart and lung apparatus to cardiac surgery. Minn Med. 1954;37:171-80.
13. Kirklin JW, DuShane JW, Patrick RT, Donald DE, HetzeI PS, Harshbarger HG, et al. Intracardiac surgery with aid of mechanical pump-oxygenator system (Gibbon type): report of eight cases. Mayo Clin Proc. 1955;30:201-6.
14. Starr A, Edwards ML, McCord CW, Griswold HE. Aortic replacement: clinical experience with a semirigid ball-valve prosthesis. Circulation. 1963;27:779-83.
15. Beall AC, Bloodwell RD, Bricker DL, Okies JE, Cooley DA, DeBakey ME. Prosthetic replacement of cardiac valves. Five and one-half years' experience. Am J Cardiol. 1969;23:250-7.
16. Cooley DA, Okies JE, Wukasch DC, Sandiford FM, Hallman GL. Ten-year experience with cardiac valve replacement: results with a new mitral prosthesis. Ann Surg. 1973;177:818-26.
17. Björk VO. A new tilting disc valve prosthesis. Scand J Thorac Cardiovasc Surg. 1969;3:1-10.
18. Björk VO. The pyrolytic carbon occluder for the Björk-Shiley tilting disc valve prosthesis. Scand J Thorac Cardiovasc Surg. 1972;6:109-13.
19. Björk VO, Lindblom D. The monostrut Björk-Shiley heart valve. J Am Coll Cardiol. 1985;6:1142-8.
20. Emery RW, Palmquist WE, Mettler E, Nicoloff DM. A new cardiac valve prosthesis: in vitro results. Trans Am Soc Artif Int Organs. 1978;24:550-6.
21. Crews TL, Frank MJ, Ellison RG, Teabeaut JR, Harper HT 3rd. Ball variance: a potentially lethal degeneration of the Starr-Edwards aortic valve poppet. J Med Assoc Ga. 1970;59:135-9.
22. Silver MD, Butany J. Mechanical heart valves: methods of examination, complications, and modes of failure. Hum Pathol. 1987;18:577-85.
23. Cotrufo M, Festa M, Renzulli A, deLuca L, Sante P, Giannolo B. Clinical results after cardiac valve replacement with the Soren prosthesis: a 6-year experience. Eur J Cardiothorac Surg. 1988;2:355-9.
24. Lund O, Nielsen SL, Arildsen H, Ilkjaer LB, Pilegaard HK. Standard aortic St Jude valve at 18 years: performance profile and determinants of outcome. Ann Thorac Surg. 2000;69:1459-65.
25. Edmunds LH Jr. Thrombotic and bleeding complications of prosthetic heart valves. Ann Thorac Surg. 1987;44:430-45.
26. Arvay A, Lengyel M. Incidence and risk factors of prosthetic valve endocarditis. Eur J Cardiothorac Surg. 1988;2:340-2.
27. Carpentier A, Lemaigre G, Robert L, Carpentier S, Dubost C. Biological factors affecting long-term results of valvular heterografts. J Thorac Cardiovasc Surg. 1969;58:467-83.
28. Reis RL, Hancock WD, Yarbrough JW, Glancy DL, Morrow AG. The flexible stent: a new concept in the fabrication of tissue heart valve prostheses. J Thorac Cardiovasc Surg. 1971;62:683-9.
29. Glower DD, Landolfo KP, Cheruvu S, Cen YY, Harrison JK, Bashore TN, et al. Determinants of 15-year outcome with 1,119 standard Carpentier-Edwards porcine valves. Ann Thorac Surg. 1998; 66(suppl):S44-8.
30. Burdon TA, Miller DC, Oyer PE, Mitchell RS, Stinson EB, Starnes VA, et al. Durability of porcine valves at fifteen years in a representative North American patient population. J Thorac Cardiovasc Surg. 1992;103:238-52.
31. Pelletier LC, Carrier M. Bioprosthetic heart valves: 25 years of development and clinical experience: In: Acar J, Bodnar E, editors. Textbook of acquired heart valve disease. London: ICR Publishers; 1995, p. 920-56.
32. Masters RG, Walley VM, Pipe AL, Keon WJ. Long-term experience with the Ionescu-Shiley pericardial valve. Ann Thorac Surg. 1995; 60(suppl):S288-91.
33. Magilligan DJ. The future of bioprosthetic valves. Trans Am Soc Artif Intern Organs. 1988;34:1031-2.
34. Ross DN. Homograft replacement of the aortic valve. Lancet. 1962; 2:487.
35. Barratt-Boyes B. Homograft aortic valve replacement in aortic incompetence and stenosis. Thorax. 1964;19:131-50.
36. Bigelow WG, Trimble AS, Aldridge HE, Bedard P, Spratt EH, Lansdown EL. The problem of insufficiency following homograft replacement of the aortic valve. J Thorac Cardiovasc Surg. 1967;54:478-90.
37. O'Brien MF, Stafford EG, Gardner MAH, Pohlner PG, McGiffin DC. A comparison of aortic valve replacement with viable cryopreserved and fresh allograft valves, with a note on chromosomal studies. J Thorac Cardiovasc Surg. 1987;94:812-23.
38. O'Brien MF, Stafford EG, Gardner MAH, Pohlner PG, Tesar PJ, Cochrane AD, et al. Allograft aortic valve replacement: long-term follow-up. Ann Thorac Surg. 1995;60(suppl)S65-70.
39. Mitchell MB, Campbell DN, Bishop DA, Clarke DR. Aortic allografts for left ventricular outflow tract replacement in children: In: Williams WG, editor. Pediatric cardiac surgery annual of the seminars in thoracic and cardiovascular surgery. Vol 3. Philadelphia: WB Saunders; 2000, p. 153-64.
40. Ross DN. Replacement of the aortic and mitral valves with a pulmonary autograft. Lancet. 1967;2:956-8.
41. Stelzer P, Elkins RC. Pulmonary autograft: an American experience. J Card Surg. 1987;2:429-33.
42. Elkins RC, Lane MM, McCue C, Ward KE. Pulmonary autograft root replacement: mid-term results. J Heart Valve Dis. 1999;8:499-503.
43. Champsaur G, Robin J, Curtil A, Tronc F, Vedrinne C, Sassolas F, et al. Long-term clinical and hemodynamic evaluation of porcine valved conduits implanted from the right ventricle to the pulmonary artery. J Thorac Cardiovasc Surg. 1998;116:793-804.
44. Niwaya K, Knott-Craig CJ, Lane MM, Chandrasekaren K, Overholt ED, Elkins RC. Cryopreserved homograft valves in the pulmonary position: risk analysis for intermediate-term failure. J Thorac Cardiovasc Surg. 1999;117:141-6.
45. Hoekstra F, Knoop C, Vaessen L, Wassenaar C, Jutte N, Bos E, et al. Donor-specific cellular immune response against human cardiac valve allografts. J Thorac Cardiovasc Surg. 1996;112:281-6.
46. Mohler ER 3rd. Are atherosclerotic processes involved in aortic-valve calcification? Lancet. 2000;356:524-5.
47. Clarke DR, Bishop DA. Pulmonary valve allografts for right ventricular outflow tract reconstruction in the pediatric population: In: Hopkins RA, editor. Cardiac reconstructions with allograft valves. New York: Bertelsmann. In press.
48. O'Brien MF, McGiffin DC, Stafford EG. Allograft aortic valve implantation: techniques for all types of aortic valve and root pathology. Ann Thorac Surg. 1989;48:600-9.
49. Simon A, Wilhelmi M, Steinhoff G, Harringer W, Brucke P. Cardiac valve endothelial cells: relevance in the long-term function of biologic valve prostheses. J Thorac Cardiovasc Surg. 1998;116:609-16.
50. Green MK, Walsh MD, Dare A, Hogan PG, Zhao XM, Frazer IH, et al. Histologic and immunohistochemical responses after aortic valve allografts in the rat. Ann Thorac Surg. 1998;66(suppl):S216-20.
51. Hawkins JA, Breinholt JP, Lambert LM, Fuller TC, Profaizer T, McGough EC, et al. Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients. J Thorac Cardiovasc Surg. 2000;119:324-30.
52. Van Nooten G, Caes F, Francois K, Missault L, van Bellegham Y. Clinical experience with the first 100 ATS heart valve implants. Cardiovasc Surg. 1996;4:288-92.
53. Banbury MK, Cosgrove DM 3rd, Lytle BW, Smedira NG, Sabik JF, Saunders CR. Long-term results of the Carpentier-Edwards pericardial aortic valve: a 12-year follow-up. Ann Thorac Surg. 1998;66(suppl): S73-6.
54. Park SZ, Reardon MJ. Current status of stentless aortic xenografts. Curr Opin Cardiol. 2000;15:74-81.
55. Sintek CF, Pfeffer TA, Kochamba GS, Jun KL, Fletcher AD, Khonsari S. Freestyle valve experience: technical considerations and mid-term results. J Card Surg. 1998;13:360-8.
56. Zund G, Breuer CK, Shinoka T, Ma PX, Langer R, Mayer JE, et al. The in vitro construction of a tissue engineered bioprosthetic heart valve. Eur J Cardiothorac Surg. 1997;11:493-7.
57. O'Brien MF, Goldstein S, Walsh S, Black KS, Elkins R, Clarke D. The SynerGraft valve: a new acellular (non-glutaraldehyde fixed) tissue heart valve for autologous recellularization. First experimental studies before clinical implantation. Semin Thorac Cardiovasc Surg. 1999;11(suppl):194-200.
58. Goldstein S, Clarke DR, Walsh SP, Black KS, O'Brien MF. Transpecies heart valve transplant: advanced studies of a bioengineered xenoautograft. Ann Thorac Surg. 2000;70:1962-9.
59. Elkins RC, Dawson PE, Goldstein S, Walsh SP, Black KS. Decellularized human valve allografts. Ann Thorac Surg. 2001;71(suppl):S428-32.
60. Denton TA, Chaux A, Matloff JM. A cardiothoracic surgery information system for the next century: implications for managed care. Ann Thorac Surg. 1995;59:486-93.